- Home
- AMBI vs VOR Comparison
AMBI vs VOR Comparison
Compare AMBI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- VOR
- Stock Information
- Founded
- AMBI 1995
- VOR 2015
- Country
- AMBI Brazil
- VOR United States
- Employees
- AMBI N/A
- VOR N/A
- Industry
- AMBI Environmental Services
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- AMBI Industrials
- VOR Health Care
- Exchange
- AMBI Nasdaq
- VOR Nasdaq
- Market Cap
- AMBI 265.0M
- VOR 261.2M
- IPO Year
- AMBI N/A
- VOR 2021
- Fundamental
- Price
- AMBI $4.95
- VOR $2.17
- Analyst Decision
- AMBI
- VOR Buy
- Analyst Count
- AMBI 0
- VOR 6
- Target Price
- AMBI N/A
- VOR $3.90
- AVG Volume (30 Days)
- AMBI 7.1K
- VOR 4.9M
- Earning Date
- AMBI 01-01-0001
- VOR 08-12-2025
- Dividend Yield
- AMBI N/A
- VOR N/A
- EPS Growth
- AMBI N/A
- VOR N/A
- EPS
- AMBI N/A
- VOR N/A
- Revenue
- AMBI $525,221,427.00
- VOR N/A
- Revenue This Year
- AMBI N/A
- VOR N/A
- Revenue Next Year
- AMBI N/A
- VOR N/A
- P/E Ratio
- AMBI N/A
- VOR N/A
- Revenue Growth
- AMBI 25.42
- VOR N/A
- 52 Week Low
- AMBI $3.70
- VOR $0.13
- 52 Week High
- AMBI $8.20
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- AMBI 53.80
- VOR 55.72
- Support Level
- AMBI $4.51
- VOR $1.97
- Resistance Level
- AMBI $5.07
- VOR $2.32
- Average True Range (ATR)
- AMBI 0.30
- VOR 0.18
- MACD
- AMBI -0.00
- VOR -0.02
- Stochastic Oscillator
- AMBI 51.16
- VOR 78.57
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.